Cabaletta Bio Inc
NASDAQ:CABA
Income Statement
Earnings Waterfall
Cabaletta Bio Inc
Revenue
|
0
USD
|
Operating Expenses
|
-74.7m
USD
|
Operating Income
|
-74.7m
USD
|
Other Expenses
|
7m
USD
|
Net Income
|
-67.7m
USD
|
Income Statement
Cabaletta Bio Inc
Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||||||||||
Operating Expenses |
(13)
|
(15)
|
(19)
|
(23)
|
(27)
|
(30)
|
(34)
|
(36)
|
(39)
|
(42)
|
(46)
|
(50)
|
(52)
|
(52)
|
(54)
|
(58)
|
(61)
|
(68)
|
(75)
|
|
Selling, General & Administrative |
(4)
|
(5)
|
(7)
|
(9)
|
(11)
|
(12)
|
(12)
|
(12)
|
(13)
|
(13)
|
(14)
|
(14)
|
(15)
|
(15)
|
(15)
|
(16)
|
(16)
|
(17)
|
(19)
|
|
Research & Development |
(9)
|
(10)
|
(12)
|
(14)
|
(16)
|
(19)
|
(21)
|
(23)
|
(26)
|
(28)
|
(32)
|
(35)
|
(37)
|
(37)
|
(39)
|
(43)
|
(45)
|
(50)
|
(55)
|
|
Operating Income |
(13)
N/A
|
(15)
-15%
|
(19)
-25%
|
(23)
-21%
|
(27)
-19%
|
(30)
-13%
|
(34)
-11%
|
(36)
-5%
|
(39)
-8%
|
(42)
-8%
|
(46)
-11%
|
(50)
-7%
|
(52)
-4%
|
(52)
0%
|
(54)
-5%
|
(58)
-7%
|
(61)
-5%
|
(68)
-11%
|
(75)
-10%
|
|
Pre-Tax Income | ||||||||||||||||||||
Interest Income Expense |
1
|
1
|
2
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
3
|
5
|
7
|
|
Total Other Income |
(6)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(18)
N/A
|
(13)
+26%
|
(17)
-26%
|
(21)
-23%
|
(26)
-23%
|
(29)
-15%
|
(33)
-13%
|
(36)
-7%
|
(39)
-8%
|
(42)
-8%
|
(46)
-11%
|
(50)
-7%
|
(51)
-4%
|
(51)
+0%
|
(53)
-4%
|
(56)
-5%
|
(57)
-3%
|
(62)
-9%
|
(68)
-8%
|
|
Net Income | ||||||||||||||||||||
Income from Continuing Operations |
(18)
|
(13)
|
(17)
|
(21)
|
(26)
|
(29)
|
(33)
|
(36)
|
(39)
|
(42)
|
(46)
|
(50)
|
(51)
|
(51)
|
(53)
|
(56)
|
(57)
|
(62)
|
(68)
|
|
Net Income (Common) |
(23)
N/A
|
(19)
+20%
|
(22)
-19%
|
(21)
+6%
|
(26)
-23%
|
(29)
-15%
|
(33)
-13%
|
(36)
-7%
|
(39)
-8%
|
(42)
-8%
|
(46)
-11%
|
(50)
-7%
|
(51)
-4%
|
(51)
+0%
|
(53)
-4%
|
(56)
-5%
|
(57)
-3%
|
(62)
-9%
|
(68)
-8%
|
|
EPS (Diluted) |
-1.03
N/A
|
-0.83
+19%
|
-0.93
-12%
|
-0.92
+1%
|
-1.11
-21%
|
-1.26
-14%
|
-1.44
-14%
|
-1.48
-3%
|
-1.55
-5%
|
-1.93
-25%
|
-1.8
+7%
|
-1.71
+5%
|
-1.76
-3%
|
-1.78
-1%
|
-1.81
-2%
|
-1.57
+13%
|
-1.46
+7%
|
-1.42
+3%
|
-1.65
-16%
|